Article
Epigenetic analysis of patients with T-ALL identifies poor outcomes and a hypomethylating agent-responsive subgroup
26 May 2021
Abstract excerpt
) delayed tumor progression. These findings suggest that epigenetic-based therapies may provide an alternative treatment option in hypermethylated T-ALL.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
